Document is current
Any future updates will be listed below
-
Authors
Langness, Vanessa F.
Simmons, Danielle A. https://orcid.org/0000-0002-6122-840X
Kaur, Sukhneet
Massa, Stephen M.
Longo, Frank M. https://orcid.org/0000-0002-9514-7325
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 8 May 2026
First Online: 28 May 2026
Declarations
:
: Not applicable.
: Not applicable.
: F.M.L and S.M.M. are listed as inventors on patents relating to p75 NTR modulation, which are assigned to UNC, UCSF, and the VA. Drs. Longo and Massa are eligible for royalties distributed by the assigned universities. Dr. Longo has financial interest in PharmatrophiX, a company focused on the development of small-molecule ligands for neurotrophin receptors, which has licensed several of these patents. V.F.L., D.A.S., and S.K. declare that they have no competing interests.
